A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

NCT01098240 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

297

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Major Depressive Disorder

Interventions

DRUG: CP-601,927
OTHER: Placebo

Sponsor

Pfizer